Archives

The United States Senate is currently considering legislation that would benefit trial lawyers at the expense of consumers and innovative drug manufacturers. Proponents claim the Creating and Restoring Equal Access to Equivalent Samples (“CREATES”) Act (Pat Leahy D-VT) would provide a more efficient path for generic drug manufacturers to bring their product to market. In reality, the legislation is nothing but a giveaway to greedy personal injury lawyers and generic drug manufacturers. . . . → Read More: “CREATES Act” is Nothing but a Giveaway to Well-Heeled Personal Injury Lawyers